These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24002537)

  • 1. MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant?
    Sautter-Bihl ML; Hohenberger W; Fietkau R; Roedel C; Schmidberger H; Sauer R
    Ann Surg Oncol; 2014 Jan; 21(1):197-204. PubMed ID: 24002537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study.
    Strassburg J; Ruppert R; Ptok H; Maurer C; Junginger T; Merkel S; Hermanek P
    Ann Surg Oncol; 2011 Oct; 18(10):2790-9. PubMed ID: 21509631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
    Glynne-Jones R; Mawdsley S; Novell JR
    Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.
    Wieder HA; Rosenberg R; Lordick F; Geinitz H; Beer A; Becker K; Woertler K; Dobritz M; Siewert JR; Rummeny EJ; Stollfuss JC
    Radiology; 2007 Jun; 243(3):744-51. PubMed ID: 17463134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resectable rectal cancer: which patient does not need preoperative radiotherapy?
    Kulu Y; Ulrich A; Büchler MW
    Dig Dis; 2012; 30 Suppl 2():118-25. PubMed ID: 23207943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge.
    Engelen SM; Maas M; Lahaye MJ; Leijtens JW; van Berlo CL; Jansen RL; Breukink SO; Dejong CH; van de Velde CJ; Beets-Tan RG; Beets GL
    Eur J Cancer; 2013 Jul; 49(10):2311-20. PubMed ID: 23571146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
    Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
    J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
    Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
    Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of preoperative magnetic resonance imaging of the pelvis in rectal cancer.
    Martling A; Holm T; Bremmer S; Lindholm J; Cedermark B; Blomqvist L
    Br J Surg; 2003 Nov; 90(11):1422-8. PubMed ID: 14598425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance in rectal cancer treatment.
    van de Velde CJ; van den Broek CB
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal cancer: review with emphasis on MR imaging.
    Beets-Tan RG; Beets GL
    Radiology; 2004 Aug; 232(2):335-46. PubMed ID: 15286305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and imaging of low rectal carcinoma.
    Salerno G; Daniels I; Heald RJ; Brown G; Moran BJ
    Surg Oncol; 2004; 13(2-3):55-61. PubMed ID: 15572087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
    Taylor FG; Quirke P; Heald RJ; Moran BJ; Blomqvist L; Swift IR; Sebag-Montefiore D; Tekkis P; Brown G;
    J Clin Oncol; 2014 Jan; 32(1):34-43. PubMed ID: 24276776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rectal cancer: current status of multimodal therapy--when and how?].
    Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
    Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer].
    Rödel C; Sauer R; Fietkau R
    Strahlenther Onkol; 2009 Aug; 185(8):488-92. PubMed ID: 19652930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological short-term effects and adverse events of MRI-guided selective neoadjuvant radiochemotherapy for rectal cancer.
    Maurer CA; Mattiello D; Duwe J; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
    Anticancer Res; 2012 May; 32(5):1721-8. PubMed ID: 22593452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study.
    Frasson M; Garcia-Granero E; Parajó A; Garcia-Mayor L; Flor B; Garcia-Granero A; Lavery I
    Colorectal Dis; 2015 Aug; 17(8):689-97. PubMed ID: 25735444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.
    Kusters M; Marijnen CA; van de Velde CJ; Rutten HJ; Lahaye MJ; Kim JH; Beets-Tan RG; Beets GL
    Eur J Surg Oncol; 2010 May; 36(5):470-6. PubMed ID: 20096534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.